AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 39(2), 1988, pp. 191-195
Copyright © 1988 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, K.-P.
Right arrow Articles by Chen, E.-R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, K.-P.
Right arrow Articles by Chen, E.-R.

Larvicidal Effect of Albendazole against Angiostrongylus Cantonensis in Mice

Kao-Pin Hwang AND Eng-Rin Chen
Department of Parasitology, Kaohsiung Medical College, Kaohsiung, Taiwan, Republic of China

Mice were infected with 50 third stage larvae of Angiostrongylus cantonensis and treated orally with albendazole (Zentel®) in dosages of 5, 10, and 25 mg/kg/day begun 5, 10, or 15 days post-infection for 7, 14, or 21 consecutive days. The mice in each group were killed 3 days after cessation of treatment and the brains examined for parasites. Worms were recovered from the brains of all mice treated for 7 days, but recoveries from treated mice were significantly lower than from controls. Worm reduction was nearly 100% in mice treated for 14 days when treatment was initiated 5 and 10 days post-infection. Worms were found in the brain of mice treated for 14 days when treatment began at 15 and 20 days, but recovery rates were significantly lower than in controls. Similar results were obtained in animals treated for 21 days. Worm reduction rates were lower in animals given 5 mg/kg/day, but there was no significant difference in animals given higher dosages. Albendazole was effective in the treatment of A. cantonensis in mice when given within 15 days post-infection.

Accepted for publication January 24, 1988.




This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
K.-M. Chen and S.-C. Lai
Biochemical and pathological evaluation of albendazole/thalidomide co-therapy against eosinophilic meningitis or meningoencephalitis induced by Angiostrongylus cantonensis
J. Antimicrob. Chemother., February 1, 2007; 59(2): 264 - 276.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
V. CHOTMONGKOL, K. SAWADPANITCH, K. SAWANYAWISUTH, S. LOUHAWILAI, and P. LIMPAWATTANA
TREATMENT OF EOSINOPHILIC MENINGITIS WITH A COMBINATION OF PREDNISOLONE AND MEBENDAZOLE
Am J Trop Med Hyg, June 1, 2006; 74(6): 1122 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
L.-C. Wang, S.-M. Jung, C.-C. Chen, H.-F. Wong, D.-P. Wan, and Y.-L. Wan
Pathological changes in the brains of rabbits experimentally infected with Angiostrongylus cantonensis after albendazole treatment: histopathological and magnetic resonance imaging studies
J. Antimicrob. Chemother., February 1, 2006; 57(2): 294 - 300.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
W.-Y. Du, J.-W. Liao, C.-K. Fan, and K.-E. Su
Combined Treatment with Interleukin-12 and Mebendazole Lessens the Severity of Experimental Eosinophilic Meningitis Caused by Angiostrongylus cantonensis in ICR Mice
Infect. Immun., July 1, 2003; 71(7): 3947 - 3953.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
O. H. D. Brutto, J. Sotelo, R. Aguirre, E. Diaz-Calderon, and T. A. Alarcon
Albendazole Therapy for Giant Subarachnoid Cysticerci
Arch Neurol, May 1, 1992; 49(5): 535 - 538.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Society of Tropical Medicine and Hygiene.